Jon Bell is a Senior Director within AstraZeneca’s Alliance and Integration Team, based in Cambridge UK.  He has over 25 years’ experience in the Pharma Industry and has worked for AstraZeneca for a total of 15 years.  Jon was involved in implementing the alliance between AstraZeneca and Merck for LYNPARZA, bringing together over 20 markets globally to co-commercialise the asset and working with Finance leads to align on a joint financial planning process, which met the needs of the Alliance and the Planning Cycles of the two companies.  In 2019, Jon worked on the deal team for the ground-breaking alliance between Daiichi Sankyo and AstraZeneca for ENHERTU, and subsequently became the Enterprise Lead for the ENHERTU and Dato-DXd alliances. He also has accountability for smaller alliances in Respiratory and Cardiovascular disease.